Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention
Abstract
Share and Cite
Wolf, U.; Drewas, L.; Ghadir, H.; Bauer, C.; Becherer, L.; Delank, K.-S.; Neef, R. Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention. Pharmaceuticals 2024, 17, 1587. https://doi.org/10.3390/ph17121587
Wolf U, Drewas L, Ghadir H, Bauer C, Becherer L, Delank K-S, Neef R. Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention. Pharmaceuticals. 2024; 17(12):1587. https://doi.org/10.3390/ph17121587
Chicago/Turabian StyleWolf, Ursula, Luise Drewas, Hassan Ghadir, Christian Bauer, Lars Becherer, Karl-Stefan Delank, and Rüdiger Neef. 2024. "Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention" Pharmaceuticals 17, no. 12: 1587. https://doi.org/10.3390/ph17121587
APA StyleWolf, U., Drewas, L., Ghadir, H., Bauer, C., Becherer, L., Delank, K. -S., & Neef, R. (2024). Individual Pharmacotherapy Management (IPM-II) for Patient and Drug Safety in Polypharmacy via Clinical Electronic Health Record Is Associated with Significant Fall Prevention. Pharmaceuticals, 17(12), 1587. https://doi.org/10.3390/ph17121587